Urodynamix Technologies Ltd. (TSX VENTURE: URO) announced today successful clinical test results for its near infrared spectroscopy (NIRS) technology for the evaluation of Stress Urinary Incontinence (SUI) and Overactive Bladder (OAB) in women (SUI & OAB Study).
